Pioneer & iMM-Laço Fund

Pioneer & iMM-Laço Fund

Thousands of women are diagnosed with breast cancer every day, and science has a fundamental role to play in searching for effective answers and treatments, which would renew hope for a healthier future. Pioneer is a brand dedicated to women, which supported the Laço Association from 2005 to 2015, and then renewed and strengthened this fundamental support through the creation of the iMM-Laço Fund: On the Way to a Cure. The iMM-Laço Fund is focused on promoting scientific research into breast cancer. It seeks to contribute to treating breast cancer with greater precision and to bring us closer to the solution - a cure. 

Since then, Pioneer has contributed towards:

Breast cancer screening

Breast cancer screening

State-of-the-art equipment for diagnosis and treatment in hospitals

State-of-the-art equipment for diagnosis and treatment in hospitals

The creation of centres dedicated to breast cancer, with specialised teams

The creation of centres dedicated to breast cancer, with specialised teams

Support for breast cancer research

Support for breast cancer research

A Historical Partnership

Pioneer has contributed its DNA to this cause - it has donated tonnes of paper for creating materials, which the Laço Association distributed throughout all these years, and it now continues to support the iMM-Laço Fund. Watch the video of Lynne Archibald, prior President of the Laço Association and representative of the iMM-Laço Fund.


Make a contribution

Ongoing Projects

The iMM-Laço Fund, whose office is located within the Institute of Molecular Medicine in Lisbon, is raising funds to support research and striving to discover the causes of breast cancer and the mechanisms which lead to metastatic breast cancer.

With the support of Pioneer, the iMM-Laço Fund currently finances
7 Projects:
focused on
genetics,
in order to discover
and provide more
effective treatments.
focused on the
immune system,
and on how this can help
on the path to a cure.
With the support of Pioneer, the iMM-Laço Fund currently finances

One of these projects is 100% supported by Pioneer and aims to induce the selective death of breast cancer cells through increased damage to DNA. Find out more about this project here.

iMM Testimonials

Dra. Maria do Carmo-Fonseca

iMM President

“The attention of the group I lead has always been focused on genes, on how we can study and understand genetic alterations, and how these alterations have implications which change the course of disease.”
Know more ›

Dra. Maria Mota

iMM Executive Director

“We need civil society to support us; we need civil society to get involved with us.”
Know more ›

Dr. Bruno Silva Santos

iMM Vice-President

“We have to manipulate the immune system to make it completely antitumour.”
Know more ›

Dra. Célia Carvalho

Molecular testing to assess the risk of recurrence

“If we know the genetic profile of each cancer, we can provide the most appropriate treatment for each tumour.”
Know more ›

Dra. Catarina Silveira

Sequencing tumoural DNA

“The goal is to develop techniques that are sufficiently sensitive to detect alterations in the tumoural DNA circulating in bodily fluids.”
Know more ›

Dr. Sérgio Dias

Cell research

“More recently, we have studied the interaction between the vessels, the cancer itself, and the immune system of the host to find out how these change to favour the development of cancer.”
Know more ›

Dra. Karine Serre

Manipulation of myeloid cells

“I feel inspired by being able to study the immune system and by trying to cure one of the greatest diseases of the 21st century: cancer.”
Know more ›

Dra. Sandra Casimiro

Research into metastatic disease

“All discoveries are important but I think that society and patients would like to have a faster answer.”
Know more ›

Dr. Luís Costa

Research into breast cancer’s propensity for bone metastasis

“In our laboratory, with relation to breast cancer, we are very focused on understanding why it is that this disease has a high propensity for bone metastasis.”
Know more ›
Pioneer supports this cause

Pioneer supports this cause

Find out more ›